Medication info
Balta Plus Tablet 80/12.5 mg

Balta Plus Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200807285 · Notified 2008.07.01 · Insurance code 645903760

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when prescribed as valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance of 30 mL/min or more). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy. It helps lower blood pressure effectively, reducing the burden on the cardiovascular system and improving health. It plays an important role in the treatment of essential hypertension, and you can take it with confidence.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when prescribed as valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance of 30 mL/min or more). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious harm to the fetus when administered to pregnant women; therefore, if pregnancy is confirmed, discontinue use immediately. Do not take this medication if you are allergic to it or its components, or if you have certain conditions such as specific liver diseases, kidney diseases, or hypokalemia. Patients with electrolyte imbalance or problems with kidney and liver function, elderly patients, and patients with heart failure should take this medication with special caution. This medication may cause dizziness or drowsiness; caution should be exercised when driving or operating machinery, and symptoms of hypotension should be monitored and discussed with a doctor promptly. Do not take potassium supplements or potassium-containing foods without consulting a physician, and periodically check electrolyte status and kidney function through blood tests. This medication may interact with other drugs, so if you are taking any other medications, be sure to inform your doctor or pharmacist. The hydrochlorothiazide component may cause sensitivity to sunlight, increasing the risk of skin cancer; therefore, avoid sun exposure and inform your doctor immediately if any skin abnormalities occur. This medication is not recommended for breastfeeding women; if you are breastfeeding, consult healthcare professionals before taking it. Overdose may result in symptoms such as hypotension, arrhythmia, and electrolyte disturbances; do not exceed the prescribed dosage and visit a medical facility immediately if odd symptoms occur. The safety and efficacy of this medication in children have not been established, so it is advisable not to use it in children. Store this medication in a place that avoids moisture and direct sunlight, out of the reach of children, and keep it in its original container for safety.

Side effects

Headache, dizziness, pharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, upper abdominal pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, shortness of breath, erectile dysfunction, enteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, muscle strain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, sore throat, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament strain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, anaphylaxis-like symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, increased AST, palpitations, dyspepsia, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, angioedema, rash, bullous dermatitis, joint pain, weakness, low back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, acute respiratory distress syndrome, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disturbances, depression, paresthesia, visual impairment, leukopenia, bone marrow dysfunction, hemolytic anemia, pneumonia, pulmonary edema, acute renal failure, erythema multiforme, fever, muscle cramps, acute angle-closure glaucoma, choroidal effusion, nausea, drowsiness, hypovolemia, arrhythmia, muscle rigidity

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a sealed container to prevent air and moisture from entering, and it is best to maintain a temperature below 30 degrees Celsius. Proper storage will ensure the medication's effectiveness is safely maintained.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.